Insomnia
Conditions
Keywords
longan, insomnia, efficacy, safety
Brief summary
The objectives of this study were to evaluate efficacy and safety of longan syrup in healthy volunteers with insomnia. Subjects will take 15 ml of longan syrup once a day for 3 months. They will be investigated their insomnia using Insomnia Severity Index (ISI) questionnaire, Thai- The Pittsburgh Sleep Quality Index (PSQI) questionnaire,STOP - BANG questionnaire, Epworth Sleepiness Scale (ESS) questionnaire, Actiwatch, plasma cortisol, aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), creatinine (Cr), blood urea nitrogen (BUN), fasting blood sugar, HbA1C, complete blood count (CBC), hemoglobin, lipid profile, phosphate level, saliva cortisol, and urine melatonin before and after taken longan syrup.
Interventions
DIETARY_SUPPLEMENTlongan syrup
Subjects will take 15 ml of longan syrup once a day for 3 months
DIETARY_SUPPLEMENTPlacebo syrup
Subjects will take 15 ml of placebo syrup once a day for 3 months
Sponsors
Chulalongkorn University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Caregiver)
Eligibility
Sex/Gender
ALL
Age
35 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Age 35-65 years * Insomnia severity index (ISI) more than 7 * Thai- The Pittsburgh Sleep Quality Index (PSQI)) more than 5 * STOP - BANG less than 5 * No diabetes mellitus and thyroid dysfunction * Fasting plasma glucose less than 126mg/dl * Can communication (reading and writing) * Be willing to be subjects in this study
Exclusion criteria
* Know longan allergy or have history of adverse events from longan * Take benzodiazepine, melatonin, valerian, and St Johns Wort in 1 month before this study starting * Take medicines, herbs, or food supplements including thiazide diuretics, beta-blockers ,and estrogen that have an effect on blood sugar level in 1 month before this study starting * Cannot control comorbidity diseases * Irregular working hours * Pregnancy or breast feeding * Participated in other studies
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Insomnia severity index | 3 months | Insomnia severity index after taken longan syrup will be less than before taken. The minimum and maximum values are 0 and 28 scores, respectively. Higher scores mean a worse outcome. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Thai- The Pittsburgh Sleep Quality Index | 3 months | Thai- The Pittsburgh Sleep Quality Index after taken longan syrup will be less than before taken. The minimum and maximum values are 0 and 21 scores, respectively. Higher scores mean a worse outcome. |
| Snoring, Tiredness, Observed apnea, blood Pressure, Body mass index, Age, Neck circumference and Gender questionaire | 3 months | Snoring, Tiredness, Observed apnea, blood Pressure, Body mass index, Age, Neck circumference and Gender questionaire (STOP - BANG) after taken longan syrup will not be more than before taken. The minimum and maximum values are 0 and 8 scores, respectively. Higher scores mean a worse outcome. |
| Epworth sleepiness scale | 3 months | Epworth sleepiness scale after taken longan syrup will be less than before taken. The minimum and maximum values are 0 and 24 scores, respectively. Higher scores mean a worse outcome. |
| Actiwatch value | 3 months | Actiwatch value after taken longan syrup will be better than before taken. |
| Serum cortisol | 3 months | Serum cortisol value at 8.00 o'clock (normal value 5-23 mcg/dL) after taken longan syrup will not be less than before taken. |
| Saliva cortisol | 3 months | Saliva cortisol at 20.00 o'clock (normal value 3.9 +/- 0.2 nmol/L (range 2.2-4.1 nmol/L)) after taken longan syrup will not be more than before taken. |
| Urine Melatonin | 3 months | Urine Melatonin overnight (in ng/mL) after taken longan syrup will not be less than before taken. |
| Serum Low-density lipoprotein | 3 months | Serum Low-density lipoprotein (in mg/dL) after taken longan syrup will not be more than before taken. |
| Serum High-density lipoprotein | 3 months | Serum High-density lipoprotein (in mg/dL) after taken longan syrup will not be more than before taken. |
| Serum total cholesterol | 3 months | Serum total cholesterol (in mg/dL) after taken longan syrup will not be more than before taken. |
| Complete blood count | 3 months | Complete blood count (in 10\^6 cells/mcl ) after taken longan syrup will not be more than before taken. |
| Glycohemoglobin | 3 months | Glycohemoglobin (Hemoglobin A1c) (in %) after taken longan syrup will not be more than before taken. |
| Fasting plasma glucose | 3 months | Fasting plasma glucose (in mg/dL) after taken longan syrup will not be more than before taken. |
| Aspartate aminotransferase in serum | 3 months | Aspartate aminotransferase (in U/L ) after taken longan syrup will not be more than before taken. |
| Alanine aminotransferase in serum | 3 months | Alanine aminotransferase (in U/L ) after taken longan syrup will not be more than before taken. |
| Alkaline phosphatase in serum | 3 months | Alkaline phosphatase (in U/L ) after taken longan syrup will not be more than before taken. |
| Serum creatinine | 3 months | Serum creatinine (in mg/dl ) after taken longan syrup will not be more than before taken. |
| Blood Urea Nitrogen | 3 months | Blood Urea Nitrogen (in mg/dl ) after taken longan syrup will not be more than before taken. |
| Hemoglobin | 3 months | Hemoglobin (in g/dl ) after taken longan syrup will not be more than before taken. |
| Phosphate level | 3 months | Phosphate level (in g/dl ) after taken longan syrup will not be more than before taken. |
| Serum triglyceride | 3 months | Serum triglyceride (in mg/dL) after taken longan syrup will not be more than before taken. |
Countries
Thailand
Contacts
Primary ContactPornanong Aramwit, Ph.D
Outcome results
None listed